Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects
- 1 January 1993
- journal article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 18 (7) , 457-466
- https://doi.org/10.1016/0306-4530(93)90039-n
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: